Excipient & Raw-Material Suppliers
Suppliers of excipients, APIs, and raw materials — operating appropriate GMP, and the object of the supplier qualification their customers must perform.
What this page does not claim
A sector is an organization’s role in the value chain, not a legal category. SPEQ maps the disciplines and standards that role typically operates under; it does not determine which apply to your organization, and a count of decoded standards measures SPEQ’s coverage.
WHAT THIS SECTOR DOES
Excipient, API, and raw-material suppliers make the inputs that manufacturers turn into finished product. Their materials become part of the medicine, so their manufacturing controls, change notification, and traceability directly determine finished-product quality — and they are the object of the supplier qualification every customer is required to perform.
REGULATORY LANDSCAPE
APIs are made under ICH Q7. Excipients follow appropriate GMP — the IPEC-PQG Good Manufacturing Practices Guide, with EXCiPACT certification as the common third-party scheme — and are pulled into the pharmaceutical framework through the customer’s obligations under EU GMP Chapter 5 (Production — including starting-material and supplier controls) and Chapter 7, and FDA 21 CFR 211.84 (testing and approval of incoming materials).
THE OVERSIGHT MODEL
The finished-product manufacturer is responsible for qualifying its suppliers and for the materials it accepts; the supplier is responsible for consistent manufacture, honest specification, and timely notification of any change. A supply/quality agreement defines specifications, change notification, and audit rights — and the manufacturer must be able to trace every material back through its supply chain.
WHAT QUALITY MEANS HERE
Appropriate GMP for the material
Applying the right standard — ICH Q7 for APIs, IPEC-PQG/EXCiPACT for excipients — rather than assuming full drug-product GMP or none at all.
Change notification & control
Proactively notifying customers of any change to process, source, or specification, so the change never surprises the finished-product manufacturer.
Supply-chain traceability
Full traceability of source and processing so the customer can meet EU GMP Chapter 5 supply-chain and falsification-risk expectations.
Being audit-ready for customers
Standing ready for the supplier qualification, audits, and questionnaires that every regulated customer is obligated to perform.
STANDARDS SPEQ DECODES · 163
Open the full library →WHERE QUALITY FAILS
- Undisclosed changes to process, source, or specification
- Specifications or certificates of analysis that do not reflect the material supplied
- Traceability gaps that expose the customer to supply-chain and falsification risk
- Applying the wrong GMP bar for the material’s intended use
KEY REGULATORY BODIES
Derived from the 163 standards SPEQ decodes for this sector.
GXP DISCIPLINES IN THIS SECTOR
Excipient & Raw-Material Suppliers: frequently asked questions
Reference answers on what a excipient & raw-material suppliers does, what governs it, and who is accountable for quality.
What GMP applies to pharmaceutical excipients?
Excipients follow appropriate GMP rather than full drug-product GMP. The reference is the IPEC-PQG Good Manufacturing Practices Guide, with EXCiPACT as the common third-party certification scheme. ICH Q7 covers active pharmaceutical ingredients, not excipients — which is precisely why the IPEC-PQG guide exists to fill that gap for excipient manufacturing.
Who is responsible for qualifying a material supplier?
The finished-product manufacturer is responsible for qualifying its suppliers and for the materials it accepts, driven by its obligations under EU GMP Chapter 5 (Production, including starting-material controls) and Chapter 7, and FDA 21 CFR 211.84 (testing and approval of incoming materials). The supplier is responsible for consistent manufacture, honest specification, and timely change notification.
Why is change notification important for a supplier?
Because the supplier’s material becomes part of the medicine, any change to process, source, or specification can affect finished-product quality. A supply/quality agreement defines specifications, change notification, and audit rights so that a change never surprises the manufacturer — an undisclosed change is a recurring failure mode in the supply chain.